SCHEMBL29290709

SCHEMBL29290709

CCCC(=O)OC(C)c1cccnc1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 3/20 0.52
CYP19A1 P11511 3/20 0.52
L3MBTL1 Q9Y468 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 1/20 0.44
KCNA5 P22460 4/20 0.43
TBXAS1 P24557 2/20 0.42
MAPT P10636 2/20 0.41
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9652762 1.00 CYP17A1 (0.52) CYP17A1CYP19A1L3MBTL1SMN1; SMN2LMNA
SCHEMBL28483924 0.84 TBXAS1 (0.44) CYP17A1CYP19A1L3MBTL1SMN1; SMN2LMNA
SCHEMBL7748909 0.83 LMNA (0.43) L3MBTL1SMN1; SMN2LMNAKCNA5TBXAS1
SCHEMBL9652095 0.81 CYP19A1 (0.48) CYP17A1CYP19A1SMN1; SMN2LMNAMAPT
SCHEMBL6242067 0.81 HCAR2 (0.51) L3MBTL1MAPTKDM4EALDH1A1HSD17B10
SCHEMBL5693685 0.81 HCAR2 (0.51) L3MBTL1MAPTKDM4EALDH1A1HSD17B10
SCHEMBL585143 0.81 HCAR2 (0.51) L3MBTL1MAPTKDM4EALDH1A1HSD17B10
Methane SCHEMBL28580094 0.80 HCAR2 (0.50) L3MBTL1MAPTKDM4EALDH1A1HSD17B10
SCHEMBL27558665 0.80 CYP17A1 (0.58) CYP17A1CYP19A1L3MBTL1SMN1; SMN2LMNA
SCHEMBL13065872 0.78 CYP17A1 (0.57) CYP17A1CYP19A1L3MBTL1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109641874-A C for target protein degradation3The glutarimide degron body of carbon connection C4医药公司 2019-04-16 CN disclosed